Pacific Biosciences of California, Inc. - Common Stock (PACB)

Competitors to Pacific Biosciences of California, Inc. - Common Stock (PACB)

BGI Genomics

BGI Genomics provides a wide range of genomic sequencing services and products. They are known for offering cost-effective sequencing solutions and have a strong presence in the global market, particularly in China. BGI competes with PacBio due to their ability to provide comprehensive sequencing services at scale and at lower price points. However, PacBio's focus on high-quality, long-read sequencing positions it favorably for certain applications that require greater depth of understanding, allowing them to carve out a niche in the more specialized genomic research community.

Illumina, Inc. 

Illumina is the leading company in the DNA sequencing market, offering a wide range of sequencing platforms that are widely adopted in both research and clinical settings. Illumina's technology emphasizes high-throughput capabilities and lower costs per sample, which appeals to many large-scale genomic studies. In contrast, Pacific Biosciences focuses on single-molecule real-time (SMRT) sequencing technology, which provides longer read lengths and greater accuracy for complex genomes, particularly advantageous in applications such as de novo sequencing. While Illumina has a competitive advantage in market share and extensive partnerships, PacBio's niche in accuracy for specific applications allows it to compete effectively in certain segments.

Oxford Nanopore Technologies Limited

Oxford Nanopore Technologies offers disruptive, portable sequencing technology that enables real-time genomic data analysis, catering particularly to a wide range of settings from lab research to field applications. They compete with Pacific Biosciences through their unique approach of providing ultra-long reads and the flexibility of their devices, which allows for diverse applications including environmental monitoring and pathogen surveillance. PacBio remains strong in accuracy and raw data quality, offering specific advantages in projects that demand high precision, often competing in benchmarks that highlight their superior data quality.

Thermo Fisher Scientific Inc. 

Thermo Fisher Scientific provides a comprehensive range of genomics products, including sequencing technologies, reagents, and bioinformatics solutions. They compete with Pacific Biosciences by offering integrated workflows that include both sequencing and analysis, catering to a broad audience of life sciences researchers and clinical labs. However, PacBio holds an advantage in long-read sequencing capabilities, which are essential for certain types of genomic research that require detailed structural analysis of DNA, thus targeting specific applications where their technology excels over Thermo Fisher's offerings.